Skip to main content
SpringerLink
Log in

Expression of myeloid antigens on lymphoblast surface in childhood acute lymphoblastic leukemia at diagnosis and its effect on early response to treatment: a preliminary report

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Immunodiagnosis of acute lymphoblastic leukemia (ALL) is based on the assessment of surface antigens. There are also cases in which both lymphoid and myeloid antigens can be found on the surface of lymphoblasts. The purpose of our research was to assess the expression of myeloid and lymphoblastic antigens in children with ALL, and to determine the impact of surface antigens on early response to treatment. 58 children [33 girls (56.9 %), 25 boys (43.2 %)] with ALL were studied. Response to treatment was assessed on days 8, 15, and 33. Univariate logistic regression analysis of the effect of myeloid antigens (MyAg) on response to treatment on days 8 and 33 revealed expression of any MyAg on lymphoblast surface as a factor associated with poor response to treatment. The multivariate logistic regression analysis of treatment response on day 33, showed that the expression of CD13 antigen on lymphoblast surface is a key factor affecting delayed remission (p = 0.03; odds ratio 0.12; 95 % CI 0.01–0.81). The expression of MyAg in childhood ALL adversely affects early response to treatment. The expression of CD13 antigen on day 33 is a key factor affecting complete remission in ALL patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Amirghofran Z, Daneshbod Y, Gholijani N, Esmaeilbeib M. The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia. Arch Iran Med. 2011;14:170–4.

    PubMed  Google Scholar 

  2. Suggs JL, Cruse JM, Lewis RE. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemia. Exp Mol Pathol. 2007;83:471–3.

    Article  PubMed  CAS  Google Scholar 

  3. Tanyeli A, Erbey F, Bayram I, Kömür M. myeloid antigen positivity in Turkish children with acute lymphoblastic leukemia lacks influence on prognosis. Asian Pac J Cancer Prev. 2010;11:1823–6.

    PubMed  Google Scholar 

  4. Abdelhaleem M. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia. Exp Mol Pathol. 2007;83:138–41.

    Article  PubMed  CAS  Google Scholar 

  5. Tong H, Wang Q, Lu C, et al. Immunophenotypic, cytogenetic, and clinical features of 207 cases of childhood acute lymphoblastic leukemia in China. J Pediatr Hematol Oncol. 2011;33:437–41.

    Article  PubMed  Google Scholar 

  6. Iwamoto S, Deguchi T, Ohta H, et al. Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Int J Hematol. 2011;94:185–92.

    Article  PubMed  Google Scholar 

  7. Putti MC, Rondelli R, Cocito MG, et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood. 1998;92:795–801.

    PubMed  CAS  Google Scholar 

  8. Preti HA, Huh YO, O’Brien SM, et al. Myeloid markers in adult acute lymphoblastic leukemia. Cancer. 1995;76:1564–70.

    Article  PubMed  CAS  Google Scholar 

  9. Lauria F, Raspadori D, Martinelli G, et al. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukemia patients: diagnosis and prognostic implications. Br J Haematol. 1994;87:286–92.

    Article  PubMed  CAS  Google Scholar 

  10. Buccheri V, Matutes E, Dyer MJ, et al. Lineage commitment in biphenotypic acute leukemia. Leukemia. 1993;7:919–27.

    PubMed  CAS  Google Scholar 

  11. Ünal S, Çetin M, Tuncer AM, et al. The prognostic impact of myeloid antigen expression in pediatric acute lymphoblastic leukemia patients. Turk J Pediatr. 2008;50:533–6.

    PubMed  Google Scholar 

  12. Pui CH, Behm FG, Singh B, et al. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood. 1990;75:198–202.

    PubMed  CAS  Google Scholar 

  13. Kalina T, Vaskova M, Mejstrikova E, et al. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens. BMC Cancer. 2005;5:1–11.

    Article  Google Scholar 

  14. Saxena A, Rai A, Raina V, et al. Expression of CD13/aminopeptidase N in precursor B-cell leukemia: role in growth regulation of B cells. Cancer Immunol Immunother. 2010;59:125–35.

    Article  PubMed  CAS  Google Scholar 

  15. Rolink AG, Andersson J, Melchers F. Molecular mechanism guiding late stages of B-cell development. Immunol Rev. 2004;197:41–50.

    Article  PubMed  CAS  Google Scholar 

  16. Nakase K, Kita K, Shiku K, et al. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasm. Am J Clin Pathol. 1996;105:761–8.

    PubMed  CAS  Google Scholar 

  17. Horibe K, Hara J, Yagi K, et al. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Int J Hematol. 2000;72:61–8.

    PubMed  CAS  Google Scholar 

  18. Sobol RE, Mick R, Royston I, et al. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med. 1987;316:1111–6.

    Article  PubMed  CAS  Google Scholar 

  19. Wiersma SR, Ortega J, Sobol E, Weinberg KI. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med. 1991;324:400–8.

    Article  Google Scholar 

  20. Cacciola E, Guglielmo P, Cacciola E, et al. CD34 expression in adult acute lymphoblastic leukemia. Leuk Lymphoma. 1995;1:31–6.

    Article  Google Scholar 

  21. Vitale A, Guarini A, Ariola C, et al. Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood. 2006;107:473–9.

    Article  PubMed  CAS  Google Scholar 

  22. Uckun FM, Sather HN, Gaynon PS, et al. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood. 1997;90:28–35.

    PubMed  CAS  Google Scholar 

  23. Campana D, Behm FG. Immunophenotyping of leukemia. J Immunol Methods. 2000;243:59–75.

    Article  PubMed  CAS  Google Scholar 

  24. Boucheix C, David B, Sebban C, et al. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters and outcome: an analysis of a prospective trial inducing 562 tested patients (LALA86). Blood. 1994;84:1603–12.

    PubMed  CAS  Google Scholar 

  25. Czuczman MS, Dodge RK, Stewart CC, et al. Value of immunopheno-type in intensively treated adult lymphoblastic leukemia. Blood. 1999;93:3931–9.

    PubMed  CAS  Google Scholar 

  26. Kurec A, Belair AS, Stefanu PA, et al. Significance of aberrant immunopheno-types in childhood acute lymphoblastic leukemia. J Cancer. 1991;67:3081–6.

    Article  CAS  Google Scholar 

  27. Larson RA, Dodge RK, Burns CP, et al. A five drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood. 1995;85:2025–37.

    PubMed  CAS  Google Scholar 

  28. Guillaume N, Penther D, Vaida I, et al. CD66c expression in B-cell acute lymphoblastic leukemia: strength and weakness. Int J Lab Hematol. 2011;33:92–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Oncology, Hematology and Chemotherapy, Upper Silesia Children’s Care Health Centre, Medical University of Silesia, 16 Medykow Str., 40-752, Katowice, Poland

    Grazyna Sobol-Milejska, Agnieszka Mizia-Malarz & Halina Wos

Authors
  1. Grazyna Sobol-Milejska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agnieszka Mizia-Malarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Halina Wos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Agnieszka Mizia-Malarz.

About this article

Cite this article

Sobol-Milejska, G., Mizia-Malarz, A. & Wos, H. Expression of myeloid antigens on lymphoblast surface in childhood acute lymphoblastic leukemia at diagnosis and its effect on early response to treatment: a preliminary report. Int J Hematol 98, 331–336 (2013). https://doi.org/10.1007/s12185-013-1397-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-013-1397-6

Keywords

Search

Navigation